Basic info
Industry
biotechnology research
Sectors
Biotechnology
biotechnology
inflammatory disease
T cells
autoimmune disease
genetic engineering
research
Health Care
cell therapy
immunotherapy
Medical
immunology
tolerance
Life Science
Date founded
2018
Funding rounds raised
T
Tr1X raised undisclosed on September 14, 2022
Investors: Neva Finventures